AgingResearch.NewsJoin free

Dopaxanthin

Dopaxanthin has been studied in 2 papers since 2020: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Dec 9, 2022: “Characterization of betalain-loaded liposomes and its bioactive potential in vivo after ingestion”.

Intervention

2 papers study it1 findingUpdated

PubChemChEBI

See all 2 papers on dopaxanthin

At a glance

The findings reach worms or flies, none yet in people. 1 lab in 1 country.

Worms or flies: a single group. Cells, mice and humans: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Fundación Séneca and 1 more
  • Model organisms2

What did studies of dopaxanthin find?

1

Studies of dopaxanthin measured one outcome, lifespan.

Lifespan

upin worms1+13%

1 study

  1. Dopaxanthin extends lifespan in worms (up to 12.93%).

    “increasing the lifespan of C. elegans up to 16.82%, 16.65%, 16.53%, and 12.93%, respectively”

    Model organismspure

    Betalain health-promoting effects after ingestion in Caenorhabditis elegans are mediated by DAF-16/FOXO and SKN-1/Nrf2 transcription factors

    Food chemistry

Latest

Related